This inventor holds 2 USPTO granted patents. Top assignee: Schering Aktiengesellschaft. Active years: 1995-1997.
Company Filing History:
Years Active: 1995-1997
Title: The Innovative Contributions of Karin G Steppuhn
Introduction
Karin G Steppuhn is a notable inventor based in Berlin, Germany. She has made significant contributions to the field of pharmaceuticals, particularly in the development of agents that address drug withdrawal symptoms. With a total of 2 patents, her work has the potential to impact many lives.
Latest Patents
Karin's latest patents include innovative pharmaceutical agents aimed at preventing the development of tolerance during treatment. One of her key inventions focuses on a pharmaceutical agent for the treatment of withdrawal symptoms. This patent describes the use of non-NMDA receptor antagonists, such as quisqualate or kainate antagonists, along with their physiologically compatible salts, for treating withdrawal symptoms following drug abuse. Additionally, her work explores the combination of these new pharmaceutical agents with NMDA antagonists.
Career Highlights
Karin G Steppuhn is associated with Schering Aktiengesellschaft, a prominent company in the pharmaceutical industry. Her role at the company has allowed her to contribute to groundbreaking research and development in her field.
Collaborations
Throughout her career, Karin has collaborated with esteemed colleagues, including David N Stephens and Lechoslaw Turski. These partnerships have further enhanced her research and innovation efforts.
Conclusion
Karin G Steppuhn's contributions to pharmaceutical innovation are noteworthy and reflect her dedication to improving treatment options for individuals facing drug withdrawal. Her work continues to pave the way for advancements in the field.